Dexmedetomidine Hydrochloride: drug will be given before induction and anesthetic doses and hemodynamics will be assessed pre- intra and postoperative
Study summary
Assessing the intra and postoperative hemodynamic stability in patients undergoing external dacrocystorhinostomy under general anesthesia using Dexmedetomidine as a preoperative sedation compared to traditional technique with intraoperative analgesia and assessing decreased anesthetic requirements intra and postoperative
Eligibility
Sex
ALL
Min age
16 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria:
patients of both sexes 16 years to 75 years of age ASA (American society of Anesthesiologists) I-III
Exclusion Criteria:
* Pediatric age group
* ASA more than III
Primary outcome measure(s)
Maintained hemodynamic values while reducing the anesthetic requirements — from 20 minutes after administering the drug till 2 hours after full recovery Measuring the heart rate and the blod pressure every 5 minutes intraoperative and for half an hour postoperative to assess hemodynamic stability
Trial sites (1)
Facility
City
Region
Status
Research Institute of Ophthalmolgy
Giza
Egypt
Recruiting
More Research Institute of Ophthalmology, Egypt trials in Egypt
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.